Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $67.12 USD
Change Today -0.45 / -0.67%
Volume 907.0K
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin R. Sayer

Chief Executive Officer, President and Director, DexCom, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 5 different industries.

See Board Relationships
56$8,083,831
As of Fiscal Year 2014

Background*

Mr. Kevin Ronald Sayer has been the Chief Executive Officer of DexCom, Inc. since January 5, 2015 and as its President since June 1, 2011. Mr. Sayer served as the Chief Operating Officer of DexCom, Inc. from January 7, 2013 to January 5, 2015. He served as the Chief Financial Officer and Secretary of Biosensors International Group, Ltd. from April 11, 2007 to December 2010 and from July 4, 2007 to November 30, 2010 respectively. He served as Healthcare and Medical Technology ...

Read Full Background

Corporate Headquarters*

6340 Sequence Drive
San Diego, California 92121

United States

Phone: 858-200-0200
Fax: --

Board Members Memberships*

Former Director
2004-N/A
Former Director and Chairman of Audit Committee
2005-N/A
Former Director and Chairman of Audit Committee
2007-Present
Chief Executive Officer, President and Director

Education*

BS 1981
Brigham Young University
Master's Degree 1983
Brigham Young University

Other Affiliations*

Annual Compensation*

Salary$325,000
Total Annual Compensation$325,000

Stock Options*

Restricted Stock Awards$7,112,850
All Other Compensation$21,981
Exercisable Options150,919
Exercisable Options Value$7,252,954
Total Value of Options$7,252,954
Total Number of Options150,919

Total Compensation*

Total Annual Cash Compensation$970,981
Total Short Term Compensation$325,000
Other Long Term Compensation$7,134,831
Total Calculated Compensation$8,083,831
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $67.12 USD -0.45

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Justin C. Dearborn Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA
Merge Healthcare Incorporated
$400.0K
Eyal Shalom Chief Executive Officer
RadView Software Ltd.
--
Lisa A. Hook Chief Executive Officer, President, Director and Member of Neutrality Committee
NeuStar, Inc.
$747.8K
Philip Bowman Chief Executive Officer and Executive Director
Smiths Group plc
1.5M GBP
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$532.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.